How Should We Consider Lupus Without Antinuclear Antibodies?

David I. Daikh, Martin Aringer

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	853-854
Number of pages	2
Journal	Arthritis Care and Research
Volume	71
Issue number	7
DOIs	https://doi.org/10.1002/acr.23714
State	Published - Jul 2019
Externally published	Yes

ASJC Scopus subject areas

Rheumatology

Access to Document

10.1002/acr.23714

Other files and links

Cite this

@article{e6290b147f58410da5818115ec831c9d,

title = "How Should We Consider Lupus Without Antinuclear Antibodies?",

author = "Daikh, {David I.} and Martin Aringer",

note = "Copyright: Copyright 2019 Elsevier B.V., All rights reserved.",

year = "2019",

month = jul,

doi = "10.1002/acr.23714",

language = "English (US)",

volume = "71",

pages = "853--854",

journal = "Arthritis Care and Research",

issn = "2151-464X",

publisher = "John Wiley & Sons Inc.",

number = "7",

}

TY - JOUR

T1 - How Should We Consider Lupus Without Antinuclear Antibodies?

AU - Daikh, David I.

AU - Aringer, Martin

N1 - Copyright: Copyright 2019 Elsevier B.V., All rights reserved.

PY - 2019/7

Y1 - 2019/7

UR - http://www.scopus.com/inward/record.url?scp=85068400835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068400835&partnerID=8YFLogxK

U2 - 10.1002/acr.23714

DO - 10.1002/acr.23714

M3 - Editorial

C2 - 30035362

AN - SCOPUS:85068400835

SN - 2151-464X

VL - 71

SP - 853

EP - 854

JO - Arthritis Care and Research

JF - Arthritis Care and Research

IS - 7

ER -